Thursday, June 20, 2013

Nine pharmas fined by EU

Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions of an antidepressant.

Lundbeck, Merck KGaA, Ranbaxy, Arrow, Resolution Chemicals, Xellia Pharmaceuticals, Alpharma - which is now part of Zoetis Products, and A.L. Industrier, have all been fined a total of €146 million.

No comments: